GenEdit Inc announced that it has received $26,000,000 in a round of funding on September 23, 2021. The transaction included participation from new investors, Eli Lilly and Company, KTB Network Co., Ltd., Company K Partners Limited, Korea Investment Partners Co. Ltd., DAYLI Partners Co., Ltd., KB Investment Co., Ltd., IMM Investment Corp., Timefolio Asset Management Co.,Ltd, returning investors, DCVC Bio, L.P., a fund managed by Data Collective, SK Holdings Co, Ltd., Investment Arm, Bow Capital and Sequoia Capital Operations LLC.